Literature DB >> 8486874

Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS.

D Kietzmann1, R Kahl, M Müller, H Burchardi, D Kettler.   

Abstract

OBJECTIVE: Measurement of hydrogen peroxide concentrations in breath condensate of mechanically ventilated patients with ARDS and with risk factors for developing ARDS.
DESIGN: Open study in intensive care patients.
SETTING: Intensive care units of the Clinics of the University of Göttingen, a primary care center. PATIENTS: 10 post-operatively ventilated patients as a control group and 26 patients with acute respiratory failure, 7 of them with ARDS, 12 with polytrauma, 4 with pneumonia, 3 with cardiogenic or nephrogenic pulmonary edema.
INTERVENTIONS: None. MEASUREMENTS: Breath condensate was collected by a special cold trap and was analysed for H2O2 by a chemiluminescence method. Daily measurements were performed for 4.2 +/- 2.6 days (mean +/- SD) as soon as possible after manifestation of respiratory failure.
RESULTS: Patients with acute respiratory failure exhibited higher H2O2 concentrations than control patients (median 95 nmol/l, range 76-144 nmol/l), with the highest median value found in the ARDS group (552 nmol/l, range 154-893). After clinical improvement, H2O2 concentrations decreased to the range of the control group.
CONCLUSION: Since high concentrations of H2O2 in breath condensate were only found in patients with ARDS or with risk factors for ARDS, the results add to the existing evidence that reactive oxygen species are associated with some acute lung diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486874     DOI: 10.1007/bf01708366

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  13 in total

1.  Atmospheric H2O2 measurement: comparison of cold trap method with impinger bubbling method.

Authors:  H Sakugawa; I R Kaplan
Journal:  Atmos Environ       Date:  1987       Impact factor: 4.798

2.  Studies on the conditioning of air in the respiratory tract.

Authors:  S INGELSTEDT
Journal:  Acta Otolaryngol Suppl       Date:  1956

Review 3.  The adult respiratory distress syndrome: definition and prognosis, pathogenesis and treatment.

Authors:  J P Wiener-Kronish; M A Gropper; M A Matthay
Journal:  Br J Anaesth       Date:  1990-07       Impact factor: 9.166

Review 4.  Current concepts on the adult respiratory distress syndrome.

Authors:  R H Demling
Journal:  Circ Shock       Date:  1990-04

5.  Oxidant activity in expired breath of patients with adult respiratory distress syndrome.

Authors:  S R Baldwin; R H Simon; C M Grum; L H Ketai; L A Boxer; L J Devall
Journal:  Lancet       Date:  1986-01-04       Impact factor: 79.321

Review 6.  Neutrophils and the adult respiratory distress syndrome.

Authors:  R M Tate; J E Repine
Journal:  Am Rev Respir Dis       Date:  1983-09

7.  Oxygen free radicals and lungs.

Authors:  A F Junod
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

8.  Transient leucopenia associated with adult respiratory distress syndrome.

Authors:  H V Thommasen; J A Russell; W J Boyko; J C Hogg
Journal:  Lancet       Date:  1984-04-14       Impact factor: 79.321

9.  Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome.

Authors:  C E Cross; T Forte; R Stocker; S Louie; Y Yamamoto; B N Ames; B Frei
Journal:  J Lab Clin Med       Date:  1990-04

10.  Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure.

Authors:  J I Sznajder; A Fraiman; J B Hall; W Sanders; G Schmidt; G Crawford; A Nahum; P Factor; L D Wood
Journal:  Chest       Date:  1989-09       Impact factor: 9.410

View more
  19 in total

Review 1.  Exhaled breath condensate collection in the mechanically ventilated patient.

Authors:  Stewart R Carter; Christopher S Davis; Elizabeth J Kovacs
Journal:  Respir Med       Date:  2012-03-06       Impact factor: 3.415

Review 2.  Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an aging populace.

Authors:  Louise Hecker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-14       Impact factor: 5.464

3.  Oxidative stress modulates PPAR gamma in vascular endothelial cells.

Authors:  Carmelo Blanquicett; Bum-Yong Kang; Jeffrey D Ritzenthaler; Dean P Jones; C Michael Hart
Journal:  Free Radic Biol Med       Date:  2010-03-17       Impact factor: 7.376

4.  The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations.

Authors:  P Krafft; P Fridrich; T Pernerstorfer; R D Fitzgerald; D Koc; B Schneider; A F Hammerle; H Steltzer
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

Review 5.  Mechanisms and function of DUOX in epithelia of the lung.

Authors:  Horst Fischer
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

6.  Ferritin and desferrioxamine attenuate xanthine oxidase-dependent leak in isolated perfused rat lungs.

Authors:  Brooks M Hybertson; Kevin G Connelly; Raquel T Buser; John E Repine
Journal:  Inflammation       Date:  2002-08       Impact factor: 4.092

Review 7.  Oxidants and the pathogenesis of lung diseases.

Authors:  Jonathan Ciencewicki; Shweta Trivedi; Steven R Kleeberger
Journal:  J Allergy Clin Immunol       Date:  2008-09       Impact factor: 10.793

8.  Eriodictyol, a plant flavonoid, attenuates LPS-induced acute lung injury through its antioxidative and anti-inflammatory activity.

Authors:  Guang-Fa Zhu; Hong-Juan Guo; Yan Huang; Chun-Ting Wu; Xiang-Feng Zhang
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

9.  Statins as a novel therapeutic strategy in acute lung injury.

Authors:  Sunit Singla; Jeffrey R Jacobson
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017

10.  Investigating the relationship between breath aerosol size and exhaled breath condensate (EBC) metabolomic content.

Authors:  Alexander J Schmidt; Eva Borras; Nicholas J Kenyon; Cristina E Davis
Journal:  J Breath Res       Date:  2020-10-06       Impact factor: 3.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.